<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.340">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>clinicopathological-features-of-neoplasia-and-epidemiology-</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/clipboard/clipboard.min.js"></script>
<script src="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/quarto-html/quarto.js"></script>
<script src="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/quarto-html/popper.min.js"></script>
<script src="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/quarto-html/tippy.umd.min.js"></script>
<script src="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/quarto-html/anchor.min.js"></script>
<link href="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/bootstrap/bootstrap.min.js"></script>
<link href="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="clinicopathological-features-of-neoplasia-and-epidemiology-_files/libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">


</head>

<body class="fullcontent">

<div id="quarto-content" class="page-columns page-rows-contents page-layout-article">

<main class="content" id="quarto-document-content">



<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B10.jpg" class="img-fluid"></p>
<section id="clinicopathological-features-of-neoplasia-and-epidemiology" class="level1">
<h1>Clinicopathological Features of Neoplasia and Epidemiology</h1>
</section>
<section id="serdar-balci-md" class="level1">
<h1>Serdar BALCI, MD</h1>
</section>
<section id="clinical-problems-caused-by-both-benign-and-malignant-tumors" class="level1">
<h1>Clinical problems caused by both benign and malignant tumors</h1>
<ul>
<li><strong>Location and pressure on/ infiltration of adjacent structures</strong></li>
<li><strong>Functional activity</strong>
<ul>
<li><strong>Hormone synthesis</strong></li>
<li><strong>Paraneoplastic syndromes</strong></li>
</ul></li>
<li><strong>Bleeding and infections</strong>
<ul>
<li><strong>Tumor ulcerates through adjacent surfaces</strong></li>
</ul></li>
<li><strong>Rupture or infarction</strong></li>
<li><strong>Cachexia or wasting</strong></li>
</ul>
</section>
<section id="effects-of-tumor-on-host" class="level1">
<h1>Effects of Tumor on Host</h1>
<ul>
<li><strong>Location</strong>
<ul>
<li><strong>1 cm pituitary adenoma → hypopituitarism</strong></li>
<li><strong>0.5 cm leiomyoma in renal artery → ischemia and hypertension</strong></li>
<li><strong>A small tumor on biliary tract → cholestasis, death</strong></li>
</ul></li>
<li><strong>Hormone production</strong>
<ul>
<li><strong>Islet cell benign and malignant tumors → hyperinsulinemia → hypoglycemia</strong></li>
<li><strong>Adrenocotical neoplasms → hyperaldesteronism</strong></li>
</ul></li>
<li><strong>Ulcer</strong>
<ul>
<li><strong>Tumors of GI tract</strong></li>
<li><strong>Intussusception</strong></li>
<li><strong>Intestinal obstruction</strong></li>
<li><strong>Infarct</strong></li>
</ul></li>
</ul>
</section>
<section id="cancer-cachexia" class="level1">
<h1>Cancer Cachexia</h1>
<p><strong>Progressive loss of body fat</strong></p>
<p><strong>Progressive loss of lean body mass</strong></p>
<p><strong>Profound weakness</strong></p>
<p><strong>Anorexia</strong></p>
<p><strong>Anemia</strong></p>
</section>
<section id="cachexia" class="level1">
<h1>Cachexia</h1>
<ul>
<li><p><strong>Correlation between</strong></p>
<ul>
<li><strong>Size and extent of spread of the cancer</strong></li>
<li><strong>Severity of the cachexia</strong></li>
</ul></li>
<li><p><strong>In tumors;</strong></p>
<ul>
<li><strong>Despite reduced food intake</strong>
<ul>
<li><strong>Normally recognized as starvation</strong></li>
</ul></li>
<li><strong>Calorie expenditure remains high</strong></li>
<li><strong>Basal metabolic rate is increased</strong></li>
</ul></li>
<li><p><strong>Cachexia is NOT caused by the nutritional demands of the tumor</strong></p></li>
<li><p><strong>Cytokines produced by the tumor and the host, rather than reduced food intake</strong></p></li>
<li><p><strong>TNF</strong></p>
<ul>
<li><strong>Produced by macrophages in response to tumor cells</strong></li>
<li><strong>Tumor cells themselves mediates cachexia</strong></li>
</ul></li>
<li><p><strong>TNF</strong></p>
<ul>
<li><strong>Suppresses appetite</strong></li>
<li><strong>Inhibits the action of lipoprotein lipase</strong></li>
<li><strong>Inhibiting the release of free fatty acids from lipoproteins</strong></li>
</ul></li>
<li><p><strong>Proteolysis-inducing factor</strong></p>
<ul>
<li><strong>A protein-mobilizing factor</strong></li>
<li><strong>Causes breakdown of skeletal muscle proteins by the ubiquitin-proteosome pathway</strong></li>
</ul></li>
<li><p><strong>No satisfactory treatment for cancer cachexia other than removal of the tumor</strong></p></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B11.png" class="img-fluid"></p>
<p><strong>Cancer cachexia: understanding the molecular basis Nature Reviews Cancer, 14, 754–762 (2014)</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B12.png" class="img-fluid"></p>
<p><strong>Cancer cachexia: understanding the molecular basis Nature Reviews Cancer, 14, 754–762 (2014)</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B13.png" class="img-fluid"></p>
<p><strong>Cancer cachexia: understanding the molecular basis Nature Reviews Cancer, 14, 754–762 (2014)</strong></p>
</section>
<section id="paraneoplastic-syndromes" class="level1">
<h1>Paraneoplastic Syndromes</h1>
<ul>
<li><strong>Symptom complexes that cannot be explained by local or distant spread of the tumor</strong></li>
<li><strong>The secretion of unexpected hormone</strong></li>
<li><strong>Important to recognize:</strong>
<ul>
<li><strong>Earliest manifestation of an occult neoplasm</strong></li>
<li><strong>Significant clinical illness and may even be lethal.</strong></li>
<li><strong>May mimic metastatic disease, changing treatment</strong></li>
</ul></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B14.png" class="img-fluid"></p>
<p><strong>Hypercalcemia due to bone metastasis is not considered as paraneoplastic</strong></p>
<p><strong>If hypercalcemia is due to PTH related protein then it is a paraneoplastic syndrome</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B15.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Hypercoagulability</strong>
<ul>
<li><strong>Leading to venous thrombosis</strong></li>
<li><strong>Nonbacterial thrombotic endocarditis</strong></li>
</ul></li>
<li><strong>Lung carcinomas</strong>
<ul>
<li><strong>Clubbing of the fingers</strong></li>
<li><strong>Hypertrophic osteoarthropathy</strong></li>
</ul></li>
</ul>
</section>
<section id="grade-derece" class="level1">
<h1>Grade (Derece)</h1>
<ul>
<li><strong>Attempts to establish</strong>
<ul>
<li><strong>Aggressiveness</strong></li>
<li><strong>Level of malignancy</strong></li>
</ul></li>
<li><strong>Based on</strong>
<ul>
<li><strong>Cytologic differentiation of tumor cells</strong></li>
<li><strong>The number of mitoses within the tumor</strong></li>
</ul></li>
<li><strong>Grade I, II, III, or IV --&gt; in order of increasing anaplasia</strong></li>
</ul>
</section>
<section id="different-grades-for-different-tumors" class="level1">
<h1>Different Grades for Different Tumors</h1>
<p><strong>Criteria for the individual grades vary with each form of neoplasia</strong></p>
<p><strong>Fuhrman Grade</strong></p>
<p><strong>Gleason Grade and Score</strong></p>
<p><strong>FIGO grade</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B16.png" class="img-fluid"></p>
<p><strong>Cancer Grading Manual</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B17.png" class="img-fluid"></p>
<p><strong>Cancer Grading Manual</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B18.png" class="img-fluid"></p>
<p><strong>Cancer Grading Manual</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B19.png" class="img-fluid"></p>
<p><strong>Cancer Grading Manual</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B110.png" class="img-fluid"></p>
<p><strong>Cancer Grading Manual</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B111.png" class="img-fluid"></p>
<p><strong>Cancer Grading Manual</strong></p>
</section>
<section id="stage-evre" class="level1">
<h1>Stage (Evre)</h1>
<p><strong>Based on</strong></p>
<p><strong>The size of the primary lesion or its extend to local tissues</strong></p>
<p><strong>Its extent of spread to regional lymph nodes</strong></p>
<p><strong>The presence or absence of metastases</strong></p>
</section>
<section id="stage" class="level1">
<h1>Stage</h1>
<ul>
<li><strong>TNM system</strong></li>
<li><strong>Based on</strong></li>
<li><strong>T0, T1, T2, T3, T4</strong>
<ul>
<li><strong>The size of the primary lesion or its extend to local tissues</strong></li>
</ul></li>
<li><strong>N0, N1, N2</strong>
<ul>
<li><strong>Its extent of spread to regional lymph nodes</strong></li>
</ul></li>
<li><strong>M0, M1</strong>
<ul>
<li><strong>The presence or absence of metastases</strong></li>
</ul></li>
<li><strong>AJCC/UICC system</strong></li>
<li><strong>Combines T, N, M</strong></li>
<li><strong>Groups under 4 stages</strong>
<ul>
<li><strong>Stage I, II, III, IV</strong></li>
<li><strong>Changes in each organ</strong></li>
</ul></li>
<li><strong>FIGO staging system for gynecologic tumors</strong></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B112.png" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B113.png" class="img-fluid"></p>
<p><strong>Atlas of Staging in Gynecological Cancer</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B114.png" class="img-fluid"></p>
<p><strong>Atlas of Staging in Gynecological Cancer</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B115.jpg" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B116.jpg" class="img-fluid"></p>
<p><strong>Arch Pathol Lab Med. 2009 Oct;133(10):1539-51</strong></p>
<p><strong>cancerstaging.org</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B117.jpg" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B118.jpg" class="img-fluid"></p>
<ul>
<li><strong>Grade</strong>
<ul>
<li><strong>Given by pathologist</strong></li>
<li><strong>Using microscope</strong></li>
<li><strong>Determining atypia, # of mitosis, …</strong></li>
</ul></li>
<li><strong>Stage</strong>
<ul>
<li><strong>Requires a team effort</strong></li>
<li><strong>Using histopathologic, radiologic, clinical features</strong></li>
<li><strong>Determining T, N, M status</strong></li>
</ul></li>
</ul>
</section>
<section id="laboratory-diagnosis-of-cancer" class="level1">
<h1>Laboratory Diagnosis of Cancer</h1>
<p><strong>Morphologic Methods</strong></p>
<p><strong>Tumor Markers</strong></p>
<p><strong>Molecular Diagnosis</strong></p>
</section>
<section id="morphologic-methods" class="level1">
<h1>Morphologic Methods</h1>
<ul>
<li><strong>Done by pathologist</strong>
<ul>
<li><strong>Macroscopic and microscopic features</strong></li>
</ul></li>
<li><strong>It is easy to diagnose normal and malignant cases</strong></li>
<li><strong>Problematic cases are the borderline ones</strong></li>
</ul>
</section>
<section id="clinical-information-is-necessary-in-all-cases-but-absolutely-necessary-in-some-cases" class="level1">
<h1>Clinical information is necessary in all casesBut absolutely necessary in some cases</h1>
<p><strong>Radiation-induced changes in the skin or mucosa can be similar to cancer</strong></p>
<p><strong>Sections taken from a healing fracture can mimic an osteosarcoma</strong></p>
<p><strong>Giant cell tumor of bone vs bone cysts vs hyperparathyroidism</strong></p>
</section>
<section id="specimen" class="level1">
<h1>Specimen</h1>
<ul>
<li><strong>Must be adequate</strong></li>
<li><strong>Representative</strong></li>
<li><strong>Properly preserved</strong>
<ul>
<li><strong>Formaldehyde</strong></li>
</ul></li>
</ul>
</section>
<section id="types-of-specimens" class="level1">
<h1>Types of Specimens</h1>
<p><strong>Radical Surgery</strong></p>
<p><strong>Excisional biopsy</strong></p>
<p><strong>Tru-cut (needle) biopsy</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B119.jpg" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B120.jpg" class="img-fluid"></p>
<p><strong>Int J Surg Case Rep. 2014; 5(1): 30–33</strong></p>
</section>
<section id="frozen-section" class="level1">
<h1>Frozen Section</h1>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B121.png" class="img-fluid"></p>
<p><strong>http://www.ihcworld.com/</strong></p>
</section>
<section id="fine-needle-aspiration" class="level1">
<h1>Fine Needle Aspiration</h1>
<ul>
<li><strong>Aspiration of cells from a mass</strong></li>
<li><strong>Followed by cytologic examination of the smear</strong></li>
<li><strong>Palpable lesions</strong>
<ul>
<li><strong>Breast</strong></li>
<li><strong>Thyroid</strong></li>
<li><strong>Lymph nodes</strong></li>
<li><strong>Salivary glands</strong></li>
</ul></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B122.jpg" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B123.png" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B124.png" class="img-fluid"></p>
<p><strong>Exfoliative Cytology</strong></p>
<p><strong>Cytologic (Papanicolaou) smears</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="immunohistochemistry" class="level1">
<h1>Immunohistochemistry</h1>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B125.png" class="img-fluid"></p>
<p><strong>Bancroft’s Theory and Practice of Histological Techniques</strong></p>
</section>
<section id="flow-cytometry" class="level1">
<h1>Flow cytometry</h1>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B126.jpg" class="img-fluid"></p>
</section>
<section id="tumor-markers" class="level1">
<h1>Tumor Markers</h1>
<p><strong>Tumor-associated enzymes, hormones, and other tumor markers in the blood</strong></p>
<p><strong>NOT for definitive diagnosis of cancer</strong></p>
<p><strong>Useful screening tests</strong></p>
<p><strong>Quantitating the response to therapy</strong></p>
<p><strong>Detecting disease recurrence</strong></p>
<p><strong>PSA</strong></p>
<p><strong>CEA</strong></p>
<p><strong>AFP</strong></p>
<p><strong>CA-125</strong></p>
<p><strong>CA19-9</strong></p>
</section>
<section id="molecular-diagnosis" class="level1">
<h1>Molecular Diagnosis</h1>
<ul>
<li><strong>Diagnosis of malignancy</strong></li>
<li><strong>PCR</strong>
<ul>
<li><strong>Lymphoid neoplasms</strong></li>
<li><strong>T cell receptor, Ig gene monoclonality</strong></li>
</ul></li>
<li><strong>FISH</strong>
<ul>
<li><strong>Translocation</strong></li>
<li><strong>Ewing Sarcoma, Lymphomas, Leukemias</strong></li>
</ul></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B127.png" class="img-fluid"></p>
<p><strong>Bancroft’s Theory and Practice of Histological Techniques</strong></p>
<ul>
<li><strong>Prognosis and behavior</strong></li>
<li><strong>FISH</strong>
<ul>
<li><strong>Her2/Neu</strong></li>
<li><strong>N-Myc</strong></li>
</ul></li>
<li><strong>Detection of minimal residual disease</strong>
<ul>
<li><strong>Detection of BCR-ABL transcripts by PCR</strong></li>
<li><strong>Residual disease in chronic myeloid leukemia</strong></li>
</ul></li>
<li><strong>Diagnosis of hereditary predisposition to cancer</strong>
<ul>
<li><strong>BRCA1</strong></li>
<li><strong>Microsatellite Instability</strong></li>
</ul></li>
<li><strong>Therapeutic decision-making</strong></li>
<li><strong>Targeted Therapy</strong></li>
<li><strong>Lung Carcinomas</strong>
<ul>
<li><strong>Mutations of the ALK kinase</strong></li>
</ul></li>
<li><strong>Melanomas</strong>
<ul>
<li><strong>BRAF V600E mutation</strong></li>
</ul></li>
<li><strong>Colon Cancers</strong>
<ul>
<li><strong>RAS mutation</strong></li>
</ul></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B128.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B129.png" class="img-fluid"></p>
<p><strong>Molecular Profiling of Tumors</strong></p>
<p><strong>Expression Profiling</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="molecular-profiling-of-tumors" class="level1">
<h1>Molecular Profiling of Tumors</h1>
<ul>
<li><strong>Whole Genome Sequencing</strong></li>
<li><strong>Tumors can contain from a handful of somatic mutations</strong>
<ul>
<li><strong>Certain childhood leukemias</strong></li>
</ul></li>
<li><strong>Tens of thousands of mutations</strong>
<ul>
<li><strong>Exposed to mutagens, skin, lung cancer</strong></li>
</ul></li>
</ul>
</section>
<section id="two-types-of-mutations" class="level1">
<h1>Two types of mutations</h1>
<ul>
<li><strong>Driver mutations </strong>
<ul>
<li><strong>change normal control of cell proliferation, differentiation, and homeostasis</strong></li>
<li><strong>drive the neoplastic process</strong></li>
<li><strong>could be therapeutic targets</strong></li>
</ul></li>
<li><strong>Passenger mutations:</strong>
<ul>
<li><strong>no effect on cell phenotype</strong></li>
<li><strong>more numerous than driver mutations</strong></li>
<li><strong>noncoding regions of the genome</strong></li>
<li><strong>have a neutral effect on growth, not conferring any advantage or disadvantage</strong></li>
</ul></li>
</ul>
</section>
<section id="driver-mutations" class="level1">
<h1>Driver mutations</h1>
<ul>
<li><strong>Recurrent</strong>
<ul>
<li><strong>Present in a substantial percentage of patients with a particular cancer</strong></li>
<li><strong>BCR-ABL fusion genes</strong></li>
</ul></li>
<li><strong>Driver mutations may be present in only a subset of tumors of a particular type</strong>
<ul>
<li><strong>4% of non–small cell lung cancers harbor an EML4-ALK tyrosine kinase fusion</strong></li>
<li><strong>Respond well to ALK inhibitors</strong></li>
</ul></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B130.png" class="img-fluid"></p>
<p><strong>A new classification</strong></p>
<p><strong>BRAF-omas???</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="factors-effecting-clinical-outcome" class="level1">
<h1>Factors effecting clinical outcome</h1>
<p><strong>Factors effecting survival</strong></p>
<p><strong>Histologic Type of Tumor</strong></p>
<p><strong>Grade</strong></p>
<p><strong>Presence of preinvasive component</strong></p>
<p><strong>Tumor size</strong></p>
<p><strong>Perineural invasion</strong></p>
<p><strong>Lympatic invasion</strong></p>
<p><strong>Venous invasion</strong></p>
<p><span style="color:#FF0000">Stage T, N, M</span></p>
<p><strong>Clues for hereditary syndromes</strong></p>
</section>
<section id="markers-used-in-pathology" class="level1">
<h1>Markers used in pathology</h1>
<p><strong>Diagnostic</strong></p>
<p><strong>Predictive</strong></p>
<p><strong>Prognostic</strong></p>
<p><strong>Therapeutic</strong></p>
</section>
<section id="product-of-a-pathologist-is-a-report" class="level1">
<h1>Product of a pathologist is a report</h1>
<p><strong>What do we expect to see in a report?</strong></p>
<p><strong>All morphologic, phenotypic, molecular features that are effecting the clinical outcome</strong></p>
<p><strong>Checklists, CAP</strong></p>
<p><strong>cap.org/cancerprotocols</strong></p>
</section>
<section id="epidemiology" class="level1">
<h1>Epidemiology</h1>
<p><strong>Epidemiologic data is used to find factors that are associated with cancer</strong></p>
<p><strong>Smoking → Lung cancer</strong></p>
<p><strong>Dietary fat and fiber → Colon cancer</strong></p>
<p><strong>Environmental, racial (hereditary), cultural influences</strong></p>
</section>
<section id="cancer-incidence" class="level1">
<h1>Cancer Incidence</h1>
<ul>
<li><strong># of new cancer patients per population</strong></li>
<li><strong>USA</strong>
<ul>
<li><strong>1.5 million new cancer cases occurred in 2011</strong></li>
<li><strong>569,000 people died of cancer</strong></li>
</ul></li>
<li><strong>Turkey</strong></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B131.jpg" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B132.png" class="img-fluid"></p>
<p><strong>http://globocan.iarc.fr/Pages/fact_sheets_population.aspx</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B133.png" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B134.png" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B135.png" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B136.png" class="img-fluid"></p>
</section>
<section id="cancer-rates-changes-over-time" class="level1">
<h1>Cancer Rates changes over time</h1>
<ul>
<li><strong>Significant increase in the overall cancer death rate among men</strong>
<ul>
<li><strong>Lung cancer, begun to drop</strong></li>
</ul></li>
<li><strong>The overall death rate among women has fallen slightly</strong>
<ul>
<li><strong>Decline in death rates for cancers of the uterine cervix, stomach, and large bowel</strong></li>
<li><strong>Striking climb in the rate of lung cancer in women</strong></li>
</ul></li>
</ul>
</section>
<section id="geographic-and-environmental-variables" class="level1">
<h1>Geographic and Environmental Variables</h1>
<ul>
<li><strong>Environmental factors are the predominant cause of the most common sporadic cancers</strong></li>
<li><strong>Geographic differences in death rates from specific forms of cancer</strong>
<ul>
<li><strong>Breast cancer</strong>
<ul>
<li><strong>4-5x higher in the United States and Europe than in Japan</strong></li>
</ul></li>
<li><strong>Stomach carcinoma</strong>
<ul>
<li><strong>7x higher in Japan than in the United States</strong></li>
</ul></li>
<li><strong>Liver cell carcinoma</strong>
<ul>
<li><strong>Relatively infrequent in the United States</strong></li>
<li><strong>Most lethal cancer among African populations</strong></li>
</ul></li>
</ul></li>
<li><strong>Environmental factors are the predominant cause of the most common sporadic cancers</strong></li>
<li><strong>These geographic differences are environmental rather than genetic in origin</strong>
<ul>
<li><strong>Nisei (second-generation Japanese living in the United States)</strong></li>
<li><strong>Have mortality rates for certain forms of cancer that are intermediate between those in natives of Japan and in Americans who have lived in the United States for many generations</strong></li>
<li><strong>The two rates come closer with each passing generation</strong></li>
</ul></li>
</ul>
</section>
<section id="environmental-carcinogens-are-everywhere" class="level1">
<h1>Environmental carcinogens are everywhere</h1>
<p><strong>In the workplace, in food, and in personal practices</strong></p>
<p><strong>Sunlight</strong></p>
<p><strong>Asbestos</strong></p>
<p><strong>Certain occupation</strong></p>
<p><strong>Certain features of diet</strong></p>
<p><strong>Cigarette smoking</strong></p>
<p><strong>Chronic alcohol consumption</strong></p>
<p><strong>Age at first intercourse</strong></p>
<p><strong>Number of sex partners</strong></p>
<ul>
<li><strong>There is no escape</strong>
<ul>
<li><strong>Everything people do to earn a livelihood, to subsist, or to enjoy life turns out to be illegal, immoral, or fattening, or—most disturbing—possibly carcinogenic.</strong></li>
</ul></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B137.png" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B138.png" class="img-fluid"></p>
</section>
<section id="questions-to-think" class="level1">
<h1>?questions to think?</h1>
<p><strong>Why do we see cancer in older people?</strong></p>
<p><strong>Why do we see cancer in newborns?</strong></p>
<p><strong>Why certain cancers have peaks at certain ages?</strong></p>
</section>
<section id="age" class="level1">
<h1>Age</h1>
<ul>
<li><strong>Most cancer deaths occur between ages 55 and 75</strong></li>
<li><strong>The rate declines, along with the population base, after age 75</strong></li>
<li><strong>The rising incidence with age</strong>
<ul>
<li><strong>Accumulation of somatic mutations</strong></li>
<li><strong>The decline in immune competence</strong></li>
</ul></li>
<li><strong>Cancer causes slightly more than 10% of all deaths among children younger than 15 years</strong></li>
<li><strong>The major lethal cancers in children</strong>
<ul>
<li><strong>Leukemias</strong></li>
<li><strong>CNS tumors</strong></li>
<li><strong>Lymphomas</strong></li>
<li><strong>Soft tissue and bone sarcomas</strong></li>
</ul></li>
</ul>
</section>
<section id="heredity" class="level1">
<h1>Heredity</h1>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B139.png" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B140.png" class="img-fluid"></p>
<ul>
<li><strong>Inheritance of a single mutant gene greatly increases the risk of developing a tumor</strong></li>
<li><strong>Carriers of mutant Rb have a 10,000-fold increased risk of developing retinoblastoma</strong></li>
<li><strong>Often are associated with a specific marker phenotype</strong>
<ul>
<li><strong>Polyps in APC</strong></li>
<li><strong>Lisch nodules and café-au-lait spots in neurofibromatosis type 1</strong></li>
</ul></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B141.png" class="img-fluid"></p>
<p><strong>characterized by chromosomal or DNA instability and high rates of certain cancers</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B142.png" class="img-fluid"></p>
<ul>
<li><strong>Features that characterize familial cancers</strong>
<ul>
<li><strong>Early age at onset</strong></li>
<li><strong>Tumors arising in two or more close relatives of the index case</strong></li>
<li><strong>Multiple or bilateral tumors</strong></li>
</ul></li>
<li><strong>Familial cancers</strong>
<ul>
<li><strong>Not associated with specific marker phenotypes</strong></li>
<li><strong>In contrast to APC, familial colonic cancers do not arise in preexisting benign polyps</strong></li>
</ul></li>
<li><strong>Incomplete penetrance or multifactorial inheritance</strong></li>
</ul>
</section>
<section id="why-all-smokers-do-not-get-cancer" class="level1">
<h1>Why all smokers do not get cancer?</h1>
<p><strong>Polymorphisms in drug-metabolizing enzymes</strong></p>
<p><strong>Genome-wide association studies (GWAS) in lung cancer</strong></p>
<p><strong>Identified variants in a nicotinic acid receptor</strong></p>
<p><strong>Associated with the number of cigarettes smoked</strong></p>
<p><strong>Indirectly increase lung cancer risk by enhancing the addictiveness of cigarettes</strong></p>
<p><strong>?My uncle used to smoke 3 packages per day, he did not get cancer?</strong></p>
</section>
<section id="acquired-preneoplastic-lesions" class="level1">
<h1>Acquired Preneoplastic Lesions</h1>
<ul>
<li><strong>Preneoplastic lesions, precancers</strong></li>
<li><strong>Precursor lesions arise in the setting of chronic tissue injury or inflammation</strong></li>
<li><strong>Squamous metaplasia and dysplasia of the bronchial mucosa</strong>
<ul>
<li><strong>Habitual smokers</strong></li>
<li><strong>A risk factor for lung cancer</strong></li>
</ul></li>
<li><strong>Endometrial hyperplasia and dysplasia</strong>
<ul>
<li><strong>Women with unopposed estrogenic stimulation</strong></li>
<li><strong>A risk factor for endometrial carcinoma</strong></li>
</ul></li>
<li><strong>Leukoplakia of the oral cavity, vulva, or penis</strong>
<ul>
<li><strong>May progress to squamous cell carcinoma</strong></li>
</ul></li>
<li><strong>Villous adenomas of the colon</strong>
<ul>
<li><strong>Associated with a high risk of transformation to colorectal carcinoma</strong></li>
</ul></li>
</ul>
</section>
<section id="what-is-the-risk-of-malignant-change-in-a-benign-neoplasm" class="level1">
<h1>What is the risk of malignant change in a benign neoplasm?</h1>
<ul>
<li><strong>Are benign tumors precancerous?</strong>
<ul>
<li><strong>Adenomas of the colon as they enlarge can undergo malignant transformation in 50% of cases</strong></li>
<li><strong>Malignant change is extremely rare in leiomyomas of the uterus</strong></li>
</ul></li>
</ul>
</section>
<section id="early-detection-of-cancer" class="level1">
<h1>Early Detection of Cancer</h1>
<ul>
<li><strong>Screening Tests</strong>
<ul>
<li><strong>Hormone Markers</strong></li>
</ul></li>
<li><strong>PAP Test</strong></li>
<li><strong>HPV Test</strong></li>
<li><strong>KETEM</strong></li>
<li><strong>kanser.gov.tr</strong></li>
</ul>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B143.jpg" class="img-fluid"></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B144.png" class="img-fluid"></p>
<p><strong>N Engl J Med 373;18 October 29, 2015</strong></p>
</section>
<section id="how-can-you-find-cancer-statistics" class="level1">
<h1>How can you find cancer statistics?</h1>
<p><strong>SEER: seer.cancer.gov/</strong></p>
<p><strong>Globocan: globocan.iarc.fr/</strong></p>
<p><strong>http://www.cancerindex.org/Turkey</strong></p>
<p><img src="img%5CClinicopathological-features-of-Neoplasia-and-Epidemiologypptx-kopyas%C4%B145.jpg" class="img-fluid"></p>
</section>

</main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>